Is it safe to take Eliquis (apixaban) with Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Taking Eliquis (Apixaban) with Lexapro (Escitalopram)

You can safely take Eliquis with Lexapro—there is no significant drug interaction between these medications, and you should not be scared to use them together.

Why This Combination Is Safe

No Metabolic Interaction

  • Escitalopram does not interfere with apixaban's metabolism. Escitalopram has negligible inhibitory effects on CYP enzymes and P-glycoprotein, meaning it is unlikely to cause clinically significant drug-drug interactions 1.
  • Apixaban is metabolized primarily by CYP3A4, CYP2C19, and CYP2D6, and is a substrate for P-glycoprotein 2. Since escitalopram doesn't meaningfully inhibit these pathways, it won't increase apixaban levels in your blood 1.

Bleeding Risk Context

  • While there is one published case report of a limb-threatening hematoma in an 85-year-old patient taking citalopram (a closely related medication to escitalopram) with apixaban 3, this represents an extremely rare event and involved the racemic mixture citalopram, not escitalopram specifically.
  • SSRIs like escitalopram can theoretically increase bleeding risk through their effect on platelet serotonin, but this is a general consideration with all anticoagulants, not a specific contraindication 3.
  • Studies examining SSRIs with direct oral anticoagulants found that non-CYP3A4 inhibiting SSRIs (which includes escitalopram) do not significantly increase bleeding risk compared to CYP3A4-inhibiting SSRIs like fluoxetine or paroxetine 4.

What Makes This Different from Problematic Combinations

The guidelines you might have read about apixaban interactions focus on strong P-glycoprotein and CYP3A4 inhibitors like:

  • Cancer medications (selpercatinib, tepotinib, osimertinib) 5
  • Cardiovascular drugs (amiodarone, diltiazem) 6

Escitalopram is NOT in this category and does not have these inhibitory properties 1.

Practical Monitoring Recommendations

  • No dose adjustment of either medication is needed based on the drug interaction profile 2, 1.
  • Be aware of general bleeding precautions while on apixaban: watch for unusual bruising, blood in urine or stool, or prolonged bleeding from cuts 2.
  • Ensure your kidney function is monitored regularly, as apixaban clearance depends on renal function 2.
  • Avoid NSAIDs (like ibuprofen or naproxen) which DO significantly increase bleeding risk with apixaban 7.

Bottom Line

The combination of Eliquis and Lexapro is considered safe and does not require special precautions beyond standard monitoring for any patient on anticoagulation. Your fear is understandable given general warnings about drug interactions, but this specific combination lacks the metabolic interaction pathways that would make it dangerous 1.

References

Research

The clinical pharmacokinetics of escitalopram.

Clinical pharmacokinetics, 2007

Guideline

Safety of Concurrent Use of Escitalopram and Apixaban

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rivaroxaban and selective serotonin reuptake inhibitors: Bleeding risk resulting from their concomitant use.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safety of Using Voltaren Gel with Eliquis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.